<SUBMISSION>
<ACCESSION-NUMBER>0001193125-05-170242
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20050816
<ITEMS>8.01
<ITEMS>9.01
<FILING-DATE>20050817
<DATE-OF-FILING-DATE-CHANGE>20050817
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DAVITA INC
<CIK>0000927066
<ASSIGNED-SIC>8090
<IRS-NUMBER>510354549
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-14106
<FILM-NUMBER>051033699
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
<PHONE>3105362400
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>601 HAWAII STREET
<CITY>EL SEGUNDO
<STATE>CA
<ZIP>90245
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE HOLDINGS INC
<DATE-CHANGED>19950524
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>TOTAL RENAL CARE INC
<DATE-CHANGED>19940719
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="4"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE
COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>Form 8-K </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Pursuant to Section 13 or 15(d) of the </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">Date of Report (date of earliest event reported): August 16, 2005 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="6"><B>DAVITA INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>1-4034</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>No. 51-0354549</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State or other<BR>jurisdiction of incorporation)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission File Number)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer <BR>Identification No.)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>601 Hawaii Street
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>El Segundo, California 90245 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="1"><B>(Address of principal executive offices including Zip Code) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>(310) 536-2400 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number, including area code) </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Not applicable </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Former name or former address, if changed since last report) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions: </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>INFORMATION TO BE INCLUDED
IN THE REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Other Events. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Attached hereto as Exhibit 99.1 is a press release issued by DaVita Inc. on August 16, 2005. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">(c) Exhibits. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT><BR><HR WIDTH="42" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated August 16, 2005.</FONT></TD></TR>
</TABLE>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2">D<SMALL>A</SMALL>V<SMALL>ITA</SMALL> I<SMALL>NC</SMALL>.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT FACE="Times New Roman" SIZE="2">Date: August 17, 2005</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ Joseph Schohl</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Joseph Schohl</B></FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>Vice President, General Counsel and Secretary</B></FONT></TD></TR>
</TABLE>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>EXHIBIT INDEX
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="1"><B>Exhibit<BR>Number</B></FONT><BR><HR WIDTH="42" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1"><B>Description</B></FONT></P><HR WIDTH="61" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Press Release of DaVita Inc., dated August 16, 2005.</FONT></TD></TR>
</TABLE>


</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g97642img1.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Contact:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">LeAnne Zumwalt</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Investor Relations</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">DaVita Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">650 696-8910</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><U>CMS Proposed Rule
Would Reduce Medicare ESRD Reimbursement </U></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">El Segundo, California, August
16, 2005 &#150; DaVita Inc. (NYSE: DVA). The Centers for Medicare and Medicaid Services (CMS) has published a proposed rule containing its 2006 Physician Fee Schedule. Included in this proposed rule are revisions to dialysis pharmaceutical payments
and the dialysis composite rate. The proposal is subject to a comment period, which ends on September 30, 2005, before final rules are published. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Specifically, the CMS proposal changes dialysis reimbursement for separately billable pharmaceuticals, including EPOGEN<FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP>&reg;<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></SUP><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT></FONT>, from average acquisition cost to average sales price plus 6%. Correspondingly, they
propose to increase the composite rate drug add-on to 8.9%. The proposed add-on of 8.9% does not accomplish budget neutrality as required by the 2003 Medicare Modernization Act. </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">The rule if implemented as proposed would effectively cut our 2006 composite rate by 2.5%, reducing DaVita&#146;s standalone 2006 Medicare
reimbursement by approximately $15-20 million. It would also have a proportional impact on the Gambro Healthcare business we are acquiring. It is our belief that CMS has made an error in their calculation. We have had an initial meeting with CMS and
will continue our dialogue with a goal of achieving budget neutrality in the final rule. </FONT></P>


</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g97642img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g97642img1.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!X17AI9@``24DJ``@````&`#$!`@`1
M````5@````$#!0`!````:`````,#`0`!`````.YQ`Q!1`0`!`````0#^_A%1
M!``!````Q`X``!)1!``!````Q`X```````!-:6-R;W-O9G0@3V9F:6-E``"@
MA@$`C[$``/_;`$,`"`8&!P8%"`<'!PD)"`H,%`T,"PL,&1(3#Q0=&A\>'1H<
M'"`D+B<@(BPC'!PH-RDL,#$T-#0?)SD].#(\+C,T,O_;`$,!"0D)#`L,&`T-
M&#(A'"$R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,O_``!$(`&`!`P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0``
M`````````0(#!`4&!P@)"@O_Q`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%
M$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U
M-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*
MDI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:
MX>+CY.7FY^CIZO'R\_3U]O?X^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#
M!`4&!P@)"@O_Q`"U$0`"`0($!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q
M$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%
M1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8
MF9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?H
MZ>KR\_3U]O?X^?K_V@`,`P$``A$#$0`_`/?J***`"BBB@`HHHH`*P_$?BK3?
M#-NC7;/+=3'%O9P+OFF;T5?Z]*FUG59K/R[/3X!<ZI<`F&%CA%`ZO(>R#\R>
M!5?1/"]OI=S)J-W*U]K$X_?7LPYQ_=0=$0=@/QS5Q26LB6V]$<M)IWQ`\7,7
MN[]/#.G,<K;VYWW!7_:88P?Q'THA^"_AP_/?W6IWTY'S22W&"3^`_K7H]%7[
M>:TCIZ$^RB]]3S*\^">AX\S2M0U'3[D?<=9=X!_0_K6#<ZWX\^&5R@U=_P"V
MM&9@HG<D_AOZJ?9LCTKVNH;JTM[ZUDM;J%)H)5VO'(N58>XIQKRVGJB716\-
M&9GAKQ1I?BO3!>Z9/N`XDB;AXF]&';^M;-?/>M:?J/PB\;0ZCIK/+IEP3L5C
MPZ9^:)O<=C]#ZU[MH^K6FNZ3;:G8R;[>X3<I[CU!]P<BBM24;2C\+'3J.7NR
MW1>HHHK`U"BBB@`HHHH`**K:A<-:6$TZ`%HUW`'O5:_U2.#2A<H?GF4>4O<D
MC^E85,13I\W,]E?Y&D*4IVLMW8TJ*:FX1KN^]@9^M.K=:F84444`%%%%`!11
M10`4444`+1110`E5=0-^+*3^S1;&[XV?:2P3KSG;STJU10@/,?&/CKQ1X*CM
M&OK719S=,P1('ER-N,DY[<BH_!WC_P`5^-9KM+'3M(@%LJEWG>7!W9P!COP:
MXKXUZG]L\;)9*V4LK=4(_P!IOF/Z%:[WX):7]C\&2WS+A[VX9@?55^4?J&KO
ME"$:"FUJSDC*4JKBGH=#*_CQ$S'!X=D;^[YDR_KBLM_B%>:!>0VOC'1'TU9C
MM2^MY/.MR?<XR/UKO:S=?T:U\0:)=Z9=HK1SQE02,[&[,/<'FN6,XMVDM#=Q
ME;W6/TN"U\IKVWF6Y:[Q(URI!\P?PX(_A`Z`?S)J_7A7P?\`%5QI>N2>%;^0
MF"5W$&X_ZN5>JCV.#^/UKW6BM3=.=F%*:G&Z"BBBLC0****`.?\`&GAN/Q5X
M7N].95\_;YENY_@E'W3_`$/L37E7P8\32Z;K,_AB])6.X9FA5O\`EG,OWE_$
M`_B/>O=:^<_B;ITWA3XCKJMD/+%PRWL)'02`_,/S&?\`@5=>&?/%TGUV.:O[
MC51'T915/2=2AUC2+34;<YBN8EE7G.,C./PZ5<KD:MH=*=PHHHH`*CF$IC/D
MLJR=1N&0?8U)12:NK#3L[G(ZY?ZH(S;74$<,3_Q)R'_&JFBK#<ZG"+N?"QX\
MM6/4]A[5J:E%)K>KK:0G$%OQ))V!/7\>U79?#.GO'MC5XG'1U8DY_&OEI8/$
M5\3*M!\\8O[3WMT5NS^1[*Q%*G15.7NMKIT-BBH+,3K:HEP0TJ_*S#^+'?\`
M&IZ^HC+FBG:QXS5G8**I7^K:?I:QF]NXH#(X2-6;YG8G`"CJ3GTJ[5V%<***
M*0!1110`4444`+1110`E(2%4L3@`9)I:Y[QSJG]C^"=7O`V'%NR)_O-\H_4T
MXKF:2$W97/F3Q'J3:SXEU+4,[OM%R[K_`+N<*/RQ7U+X6TP:-X5TO3\8:"V1
M6'^UC+?J37S)X+TK^V?&6DV.W<CW"M(/]A?F;]!7UE7=C7;E@CDPJO>3"BBJ
MVH7:V&FW5XY`2"%Y3GT4$_TK@W.P^4[^_:R\;W6H0/S#J+S(RGTD)KZSBD66
M))%(*NH8$>AKXTED:>1Y&.7D8L2>Y)K[$TZ-HM+M(W&&2%%(]PHKT,<K*)QX
M1W<BS15#6-:T_0-.DO\`4[E+>W3^)NK'T`ZD^PK@-/\`'7B7QQ?30>%-.@LM
M/B;:^HWP+8]@@XS[<^^*XXTY25^ATRFHNW4].HKBY[#Q]IL7VJWURQU=HQEK
M.:R$'F#T5U/!],\5DZ]\7[/2=,TNZMM->YEO%<RP/+Y;6[(=K*W!YW9'X4U1
ME)VCJ)U$OBT/2J\M^..DBY\,6FIJO[RSN-K'_8<8/ZA:Z[P3XHE\7Z"=5DT_
M[$AE:.-?-W[P,9;.!WR/PJ3QQIW]J>"-8M-N6:V=U'^THW#]0*=-NG55^C%.
MTZ;L<E\$M8^V^$9M-=B9+"<@`_W'^8?KNKTVOGGX):H;3QG)9%OW=[;,,?[2
M?,/TW5]#56*ARU7YDX>7-304445SFX5$\BR-);QS*LP4$@<E0<X./P/Y5E>(
MM?31H88((Q<:I>-Y5E:@\R/ZGT4=2>PIJVVH:+HDLMK;KJNKR,))MTHA$SG`
M)R0=J@<`>@`JN2ZUZBYK/0UK:VBM(1%"NU1R?4GU/O4U>2>)OBWK7AR^&GW?
MANV@O-@DPU[YH`.<?=4>E=?\/-9U?Q#X;_M?5S$K7,K&".)-JI&./J<D'K5?
M5W3IIVLNA/ME.=NIUE<Q\0=9.A>!]3NXWVS-'Y,1!P=[_*"/IDG\*V=6N=0M
M=/:73-/6_N@0%@:<1`C/)W$'I7A_Q;\2ZU>I8Z/JFE1Z:5/VDHEV)]_55)P!
MC^*KH4G.:[$5JG+%F5\*-+DUOX@6UQ<%YDL4-P[.Q;D<+R?<@_A7TG7AOPG@
M\0Z3I-UJ6F^'8]0CO7"K,]ZL)`3(P`0>Y//M7JVB:CX@O+J1-6T&+3H53*R+
M>K,6;/3``QQGFM,7>4V^B\R,/90]3<HILDB11M)(ZI&@+,S'``'4DUYKJ7Q5
M:_UE-$\&Z>-4O')'GR$K$,=2.Y`]>!]:YX4Y3V-Y34=STRBN,31_'SP>;)XK
ML([@C/D)IH:,'TW$YQ[U4G^(,^AZ)JG]OV,<>LZ:$W01/B.Z#G"O&2.AYSUQ
MBG[)OX7<7M$M]#OJ*\^\"_$J;QKJ\UDNC?98X8?->7[1OQR`!C:.O]*]!I3A
M*#M(<9J2NA:***@H2O*OCGJGV?PW8::K8:[N-[#_`&4'^+#\J]5KYW^-6I_;
M?&Z6:ME+&W5"/]IOF/Z%:Z<)'FJKR,,1*U-EOX&Z7]I\3WNI,N5M+?8I]&<_
MX*?SKWVO-O@GI?V/P7)>LN'OKAG!]57Y1^H:O2:6*ES56/#QM305Q?Q5U8:5
M\/[\!L27>+9.?[W7_P`=#5VE>#_''7A=:U9Z)$V4LT\V7'_/1N@_!?\`T*EA
MX<]1(=>7+!L\^\,:8VL>*-+T]5W>=<H&'^R#EC^0-?5^H7]MI6FW%]=R".VM
MXS([>@%>+?`_PXT^I77B&9/W5NI@MR1U<_>(^@X_X%6_\<M7>U\.V.EQMC[;
M,6D]T3!Q^97\JZ<1^]K*FC"C^[I.;/+]?UW5?B+XNA10P$THAL[;/RQ*3C/U
M[DU](^'M#M/#FAVVEV:@10K@MCEV[L?<FO$?@CHXO?%=SJ4B92P@^0GL[\#]
M`U?0-9XN235..R*PT;IS>["OE/QW-%=^/=9:T`,9NV50O0MT./JV:^E?%&L+
MH'AC4=38\V\+,GNYX4?F17SE\.]);7O'VG12CS$24W,Y/<+\W/U.!^-5@URJ
M51]!8GWG&"/HWPOI`T'POINF#[UO`JO[N>6_4FM61%EC>-QE6!4CU!IU%<3;
M;NSJ2LK'REX>G/A[XA63,2HM=0\ISG^'?M/Z$U]6U\I^/K<V7C_6T4%2+MI%
MY_O?-_6OI_1[P:CHEC>@@BXMTEX]U!KMQBNHS[G+AM'*)=K'\3>)+#PKHLNI
M7[G8ORQQK]Z1ST45:UC5[+0=*GU+4)1';PKN8]R>P`[D]`*\H\,6M[\4/%[>
M)-7B9-$L'Q:6K'*LXZ#WQP6/<X'2N:G3NG*6R-YSM[L=V=?X(TF_O)I/%GB`
M9U2]7%O">EI;GD(H[$]3_P#KKMB<#)Z45S?CW6?["\$ZG>J<2^48HO\`??Y1
M_//X4FW4F/2$3YT\5:A+XG\<7]Q#F0W-UY5N!W4'8GZ`5]0Z+IL>C:)9:;%]
MRVA6+/K@<G\3S7SK\)]%.K^/+1V4F&Q!N7/NO"_^/$?E7TQ73C))6IKH<^%5
M[S?4*^5_'^K'Q!X[U*XB^=!+]GA`[A?E&/J<G\:^CO%VL?V#X3U/4@0'A@;R
M\G^,\+^I%?/'PUT?^W/'NGQRC?%`QNI<\Y"<C/U;%/!I14JCZ!B7S-01]&>&
M=(70?#6G:6O6W@56]VZL?S)K5HK#\9:L^A^#]4U&)MLL,!\L^CGY5_4BN/6<
MO-G3I&/H>/?%GQ_+JE_-X>TV4II]NVVY=#CSY!U7/]T?J?H*[SX2^$TT'PQ'
MJ$\8&H:BHE=B.4CZHH_#D^Y]J\'\,Z4VO^*=.TUB3]IN%$A/)V]6/Y`U]<(J
MHBH@`51@`=A7;B;4H*E$Y:%ZDG4D+7A?QWN+=M:TJW3'VA+=VD(/\)8;0?Q#
M&O=*^5/&VJOXE\=:A<Q9=7G\BW'JJ_*OYXS^-9X*-ZG-V+Q4K0MW/7/@AH_V
M/PK<:FZ8DOISM)[QIP/UW5Z?6=H&EIHF@6&F)TMH%C)]2!R?Q.36C6%6?/-R
M-J<>6*0M%%%9EC20`23@#J:^1?$FI-K/B?4]0'/VBY=D_P!W.%_3%?0NN>+K
MBXT*_@T_P]KYO)8'2'?8,H#$8!)[=:\2T3P9KUOK=A-J'A[5?L<4Z/-MM68E
M0<D`=^E>AA$H7E(X\2^>R1]&^&-,&C>%],T_&#!;(K?[V,M^I-:U<Q_PFD?_
M`$+_`(B_\%S5!=^.9HHB;3PIXBN92/E4V?EC/N2>/R-<;A.3O8Z5.*5C8\2^
M(+3PQH-SJEXPVQ+A$[R.?NJ/J:^:-*TK5_B!XLD6,%[BZE,US-CY85)Y8^PZ
M`?05Z/?^#/&GQ$U6*[\0F+1].C/[JV#[V0'KA1QN/<DCZ=J].\.>&-+\*Z:+
M+3(`BGF21N7E;U8]_P"E=,)QH1=M9/\``PE"5:6ND46=%T>TT#1[;3+%-MO;
MIM7/4GN3[DY->5?'NVE-OHET!^Z1Y8V/HQ"D?^@G\J]DK#\6^&[?Q7X=N-*G
M;8SX:*7&?+D'1OZ'V)K"C4Y:BFS:K#F@XHXGX%VBQ^%;^[Q\\UX5)QV51C^9
MKU*O'/`VJW/PW%WH/BFRN+:V>8RP7L<321,2`",J#UP"/QS79OX_MM1!M_#-
ME=:O>-PI$+QPQGUDD8``>PR:NO"4JCDMGU(I2C&"3W.0^.7B%(K"S\/PN#+,
MPN)P.R#A0?J<G_@-0_`C1\1:IK3C[Q%K%^'S-_-?RJ#XA?#W45\.IK)+:EK1
MN#+J$L2GE"H`"+_<7`P.O)-2^`?&HTWP7!H>DZ->W>NAI-L0B(B)9B0[/T"@
M$9^E;Z?5^6&O<R_Y?<TSUY;^T?49-/2XC:[CC$KP@_,JDX!(_"K-<]X4\.R:
M):3W%_.+K6+Y_.O;D#AF[*OHJC@"NAKADDG9'6FVM3YH^+EOY'Q'U`A0!*D4
MG'?*`?S%>Q_#W6+=/A?IM]>7"10VL#)+(YP%",1_("O*?C7$J>/0ZYS)9QLW
MURP_I7(C7-4N]`M?#,))M!<&188U^:61CP#ZX/0>]>FZ7M:,$<"J>SJR9V>K
M:KJ?Q=\9P:78AH-+A8L@/1$!YE?_`&CT`]P/6O>=*TNTT72[?3K&(1VUN@1%
M_J?<]:YOX=^#(_!^@A)0K:E<@/=2#L>R#V'ZG)KL*XJ]1-\D/A1U4H->]+=A
M7C?QWU<K;Z7HR-]]FN91[#Y5_4M^5>R5XQ\:?"VJW^I6>M6-K+=0);^1,L*E
MFCPQ()`YP=WZ486WM5<,1?V;L:'P-T7[-H-[K$BX>\E\N,_["?\`V1/Y5Z5)
MJUC%J\.E-<+]NFB:9(0"3L4@$GTZ]Z\W\%>*]33PC8:-I'A6_>_MX_*,MPOE
M6RG)^<N>3UR0!FNW\.>'3I+7%_?SB\UF](:ZNMN!QTC0=D'8?B:*ZO.4I"I:
M12B<)\==6,&B:=I*-AKF8RN`?X4''ZL/RJO\"='"66IZTZ_-*XMHC_LK\S?J
M1^56/C-X3U3618:KIMM)=?9D:.:*(9<`G(8#OWS2_#SQ9#I'@ZWT@:'K$NI0
M,^8([1OWA+$YW'"J.>YXK9?[MRQ^9G_R_O(]+U;5;/1-,GU"^E\N"%<D]V/9
M0.Y)X`KD_&YO=9^$NHS3V36ER]N)FMBV]D57#8)'?:,GTJ]IVAZCJVIQ:UXF
M$8>$[K+3(VW1VQ_OL?XY/?H.U=1-%'/#)#*@>.12KJ>A!X(KF34&K:M&[3DF
M?._P6M5N/'WFMC-O:22+]20O_LQKZ+KQ&U\/ZE\+/'1U6*QGOM`F#Q-);H9'
MBC8@X8#G(('/<"O0!\2O#<R[;*:[OK@CY;:VLY6D8^F"H'YFM\2G4ES1U1E0
M:A'EEHRQX_\`$:>&?"%Y>!P+F1?)MQW,C#`/X<G\*\'^%^CG6?'M@KKOBM2;
MJ3/^STS_`,"*UZMK/A#5_&>G:AJ&M1)!<FV=-*T[?D6Q.#O=AP9#@#T`KS_X
M9Z[;>"M9U1-9T[4%NY8UBC2.W9G!!)*X]^/RK2C:-*2CK(BK=U(N6Q[_`'>H
M6EBUNMU<1Q-<2B&$.<%W/11[\5.[I&`795!.`2<<UQWA[3-4UK6QXH\0P?9F
M12FFZ<W)M4/5V_VV'Y"N9^)*3-KA%V76%HA]F=U)B\L1R&10!QYA;9@=3\HZ
M9KEC23ERW-W4:CS6/6J*P_!ZSKX7LQ/]HX,GE?:?]9Y/F-Y6[/.?+V=>?7FB
MLI*SL:)W5S;HHHI#"BBB@`HHHH`****`"C&***`"C`':BB@`HHHH`^?_`(YQ
MJGC"RD`^9[(;N?1VK:^#O@4KM\3ZG#R1_H,;CH.\F/T'XGTKHO%?@5_%OQ#T
M^XNT(TFUM`9F_P">K;V(C']?;ZUZ$D:Q1K'&H5%`5548``Z`5V3KVHJ$?F<T
M:-ZCFQU%%%<9TA1110`4444`%%%%`!1110`48`[444`%&!G-%%`!1C-%%`"T
&444`?__9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
